(Q51452182)

English

Merck &Co. drops osteoporosis drug odanacatib.

scientific article published in September 2016

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/27681784

title

Merck &Co. drops osteoporosis drug odanacatib. (English)

1 reference

stated in

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/27681784

0 references

1

Asher Mullard

1 reference

stated in

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/27681784

publication date

1 September 2016

1 reference

stated in

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/27681784

published in

Nature Reviews Drug Discovery

1 reference

stated in

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/27681784

volume

15

1 reference

stated in

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/27681784

issue

10

1 reference

stated in

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/27681784

page(s)

669

1 reference

stated in

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/27681784

exact match

https://scigraph.springernature.com/pub.10.1038/nrd.2016.207

0 references

Identifiers

DOI

10.1038/NRD.2016.207

1 reference

stated in

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/27681784

PubMed ID

27681784

1 reference

stated in

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/27681784

(Q51452182)

Merck &Co. drops osteoporosis drug odanacatib.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)